---
figid: PMC7407626__cells-09-01693-g004
figtitle: Summary of intrinsic apoptotic pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7407626
filename: cells-09-01693-g004.jpg
figlink: pmc/articles/PMC7407626/figure/cells-09-01693-f004/
number: F4
caption: Summary of intrinsic apoptotic pathway. BCL-2, as antiapoptotic protein,
  inhibits the formation of pores by BAX/BAK that allow cytochrome c release to the
  cytoplasm, where it interacts with Apaf-1 to constitute apoptosome, allowing caspase
  cascade. Drugs targeting apoptosis comprise dissipaters of mitochondrial membrane
  potential (ΔΨm) or BCL-2 inhibitors (blue lines) or molecules enhancing formation
  of BAX/BAK pores (red arrow).
papertitle: Role of Mitochondria in Cancer Stem Cell Resistance.
reftext: José Manuel García-Heredia, et al. Cells. 2020 Jul;9(7):1693.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.922316
figid_alias: PMC7407626__F4
figtype: Figure
redirect_from: /figures/PMC7407626__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7407626__cells-09-01693-g004.html
  '@type': Dataset
  description: Summary of intrinsic apoptotic pathway. BCL-2, as antiapoptotic protein,
    inhibits the formation of pores by BAX/BAK that allow cytochrome c release to
    the cytoplasm, where it interacts with Apaf-1 to constitute apoptosome, allowing
    caspase cascade. Drugs targeting apoptosis comprise dissipaters of mitochondrial
    membrane potential (ΔΨm) or BCL-2 inhibitors (blue lines) or molecules enhancing
    formation of BAX/BAK pores (red arrow).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - EFNA5
  - IFNGR2
  - PSMD4
  - PAF1
  - PEX2
  - CDC73
  - CTR9
  - LEO1
  - RTF1
  - SKIC8
  - CXCR1
  - BCL2
  - C2
  - BAX
  - Daunorubicin
  - Quinacrine
  - AVT-737
  - Lodinamine
  - Menadione
---
